Evidence map›Paper›PMID 28614959›Full record

ArticlePharmaceutical biology2017

The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.

Xianming Wang, Xin Zhang, Fei Liu, Minghai Wang, Shiyong Qin

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xianming Wanga Department of General Surgery , Qianfoshan Hospital affiliated to Shandong University , Shandong , China.
Xin Zhanga Department of General Surgery , Qianfoshan Hospital affiliated to Shandong University , Shandong , China.
Fei Liua Department of General Surgery , Qianfoshan Hospital affiliated to Shandong University , Shandong , China.
Minghai Wanga Department of General Surgery , Qianfoshan Hospital affiliated to Shandong University , Shandong , China.
Shiyong Qina Department of General Surgery , Qianfoshan Hospital affiliated to Shandong University , Shandong , China.
Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCombining sorafenib with triptolide could inhibit tumour growth with greater efficacy than single-agent treatment. However, their herb-drug interaction remains unknown.

objectiveThis study investigates the herb-drug interaction between triptolide and sorafenib. MATERIALS AND

methodsThe effects of triptolide (10 mg/kg) on the pharmacokinetics of different doses of sorafenib (20, 50 and 100 mg/kg) in rats, and blood samples were collected within 48 h and evaluated using LC-MS/MS. The effects of triptolide on the absorption and metabolism of sorafenib were also investigated using Caco-2 cell monolayer model and rat liver microsome incubation systems.

resultsThe results showed that the C DISCUSSION AND

conclusionsThese results indicated that triptolide could change the pharmacokinetic profiles of sorafenib in rats; these effects might be exerted via decreasing the intrinsic clearance rate of sorafenib in rat liver.

Indexed as

AnimalsAntineoplastic AgentsAntineoplastic Agents, PhytogenicBiotransformationCaco-2 CellsCytochrome P-450 CYP3ACytochrome P-450 CYP3A InhibitorsDiterpenesDose-Response Relationship, DrugDrug InteractionsEnterocytesEpoxy CompoundsFemaleHalf-LifeHumansIntestinal AbsorptionAntineoplastic AgentsAntineoplastic Agents, PhytogenicCytochrome P-450 CYP3ACytochrome P-450 CYP3A InhibitorsDiterpenesEpoxy CompoundsNiacinamidePhenanthrenesPhenylurea CompoundsProtein Kinase InhibitorsSorafenibtriptolideCYP3A4herb–drug interactionP-gp

Identifiers

PMID28614959
PMCPMC7011964
OpenAlexW2626451148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.